藥明康德(02359.HK)參股公司CANbridge於香港聯交所主板掛牌上市
格隆匯12月10日丨藥明康德(02359.HK)公吿,公司參股公司CANBRIDGEPHARMACEUTICALS INC.(以下簡稱“CANbridge”)於2021年12月10日在香港聯合交易所有限公司(以下簡稱“香港聯交所”)主板掛牌上市,股份代號:1228。CANbridge香港上市的詳細內容可在香港聯交所信息披露網站(www.hkexnews.hk)查閲。
CANbridge 本次全球發售完成後,公司通過全資子企業WuXi Pharma Tech Healthcare Fund I L.P.和WuXi AppTec(HongKong) Limited持有CANbridge的股份數為40,346,960股,佔 CANbridge 發行完成後總股本約9.51%。若後續CANbridge行使全部或部分超額配售權,公司所持CANbridge的股比將進一步被稀釋。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.